PACB NASDAQ
Pacific Biosciences of California, Inc.
1W: +3.3%
1M: -26.9%
3M: -22.4%
YTD: -32.1%
1Y: +22.6%
3Y: -89.8%
5Y: -94.7%
$1.22
-0.03 (-2.40%)
After Hours: $1.23 (+0.01, +0.82%)
Weekly Expected Move ±12.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
3 bullish
0 neutral
0 bearish
Articles (24h)
3
Hourly Sentiment (24h)
0.90
Bullish
8 bullish
0 neutral
0 bearish
Articles (7d)
8
Daily Sentiment (7 Days)
Articles (90)
Can MDT Stock Gain From Its Planned Acquisition of SPR Therapeutics?
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm
QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology
[10-Q] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Earnings Report - Stock Titan
PacBio tumbles after narrowing full-year revenue guidance
PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down
PacBio (PACB) Q1 2026 Earnings Call Transcript
PacBio expects $165M-$175M 2026 revenue as SPRQ-Nx ships later this month
Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates
Here are the major earnings after the close Thursday
PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors
Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors
PacBio & Lucid Genomics Partner to Boost Data Analysis, Stock Up
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing
Here's Why You Should Add Solventum Stock to Your Portfolio Now
Brokerages Set Pacific Biosciences of California, Inc. (NASDAQ:PACB) PT at $1.67
GEHC & DeepHealth Advance AI Breast Cancer Screening Globally
PacBio Stock Up on New FFPE Workflow Boosting Cancer Sequencing
STXS to Acquire Robocath to Lead in Endovascular Robotics Market
Here's Why You Should Add DexCom Stock to Your Portfolio Now
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
Glaukos Wins Permanent J-Code for Epioxa Keratoconus Therapy
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
Microbot Medical Begins Full U.S. Launch of LIBERTY System
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes
Stryker to Acquire AVS, Adding IVL Capabilities to Vascular Portfolio
RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data
Three Best Genomics Stocks for Your Portfolio in 2026
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study
GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery Imaging
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
GRAIL Partners With Epic to Broaden Galleri Test Access Across US
Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now
Artivion Secures FDA Approval for NEXUS Aortic Arch System
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
Revvity Gains on Diagnostics Strength, Faces China Headwinds
Here's Why You Should Add PacBio Stock to Your Portfolio Now
Here's Why You Should Add PacBio Stock to Your Portfolio Now
Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note
Analysts Set Pacific Biosciences of California, Inc. (NASDAQ:PACB) PT at $2.10
PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
PacBio Announces the Appointment of Chris Gibson to the Board of Directors
Amova Asset Management Americas Inc. Sells 540,897 Shares of Pacific Biosciences of California, Inc. $PACB
Pacific Biosciences of California, Inc. $PACB Shares Sold by ARK Investment Management LLC
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Intuitive Surgical Expands Direct Operational Presence in Europe
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub
Analysts Set Pacific Biosciences of California, Inc. (NASDAQ:PACB) PT at $2.20
Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call Transcript
PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up
Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates
PacBio Completes Sale of Short-Read Sequencing Assets
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Rating of “Hold” from Analysts
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market
PacBio: The Consumables Flywheel Is Turning. The Chart Wants Confirmation
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts
PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research
Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)
PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell
Here's Why You Should Add PacBio Stock to Your Portfolio
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up – Time to Buy?
PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference
Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.1% – Should You Sell?
Pacific Biosciences of California Target of Unusually Large Options Trading (NASDAQ:PACB)
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
Brokerages Set Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target at $2.00
Pacific Biosciences of California (NASDAQ:PACB) Shares Cross Above 200 Day Moving Average – Here’s Why